DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Neoral (Cyclosporine) - Immunosuppressant Drug Level Increased - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Immunosuppressant Drug Level Increased (38)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Neoral (Cyclosporine) where reactions include immunosuppressant drug level increased. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 38   Next >>

Possible Neoral side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-31

Patient: female

Reactions: Hypotension, Oedema, Immunosuppressant Drug Level Increased, Asthenia, Leukopenia, Anaemia Macrocytic

Drug(s) suspected as cause:
Cellcept
    Dosage: 1.5 g, bid (morning and evening)
    Administration route: Oral
    Start date: 2011-08-29

Certican
    Administration route: Oral
    Indication: Immunosuppression
    Start date: 2011-05-09

Certican
    Dosage: (0.5 mg in the morning and 0.25 mg in the evening)
    Administration route: Oral
    Start date: 2011-07-18

Cellcept
    Dosage: 1750 mg, bid (morning and evening)
    Administration route: Oral
    Start date: 2011-07-20

Neoral
    Dosage: (100 mg in morning and 75 mg in evening)

Cellcept
    Administration route: Oral
    Indication: Immunosuppression
    Start date: 2011-04-08

Valganciclovir
    Indication: Cytomegalovirus Infection
    Start date: 2011-04-08
    End date: 2012-01-11

Certican
    Dosage: 0.5 mg, bid
    Administration route: Oral
    Start date: 2012-01-11

Certican
    Dosage: 0.25 mg, bid
    Administration route: Oral
    Start date: 2011-06-20

Neoral
    Dosage: 50 mg, bid

Bactrim DS
    Dosage: unk ukn, unk
    Administration route: Oral
    Indication: Infection in AN Immunocompromised Host
    Start date: 2011-04-08
    End date: 2011-08-29

Other drugs received by patient: Pravastatin; Folic Acid; Aranesp; Ferrous Fumarate; Amlodipine Besylate; Thymoglobulin; Fungizone; Corticosteroids; Aspirin; Prednisolone; Esomeprazole; Prograf; Sporanox; Ramipril; Bactrim



Possible Neoral side effects in 32 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-31

Patient: 32 year old female

Reactions: Graft Versus Host Disease, Post Transplant Distal Limb Syndrome, Pain in Extremity, Immunosuppressant Drug Level Increased

Drug(s) suspected as cause:
Neoral
    Indication: Prophylaxis Against Graft Versus Host Disease

Neoral
    Indication: Stem Cell Transplant

Other drugs received by patient: Methotrexate



Possible Neoral side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-24

Patient: male

Reactions: Confusional State, Intraventricular Haemorrhage, Pyrexia, Fall, Posterior Reversible Encephalopathy Syndrome, Musculoskeletal Stiffness, Bone Marrow Failure, Immunosuppressant Drug Level Increased, Thrombocytopenia, Purpura, Convulsion, Mucosal Inflammation, Immunosuppressant Drug Level Decreased, Subarachnoid Haemorrhage, Aspergillosis, Asthenia, Hypertension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neoral
    Dosage: 75 mg, bid

Neoral
    Administration route: Oral
    Indication: Prophylaxis Against Graft Versus Host Disease
    Start date: 2011-04-04

Other drugs received by patient: Imipenem and Cilastatin Sodium; Valacyclovir Hydrochloride; Pentacarinat; Esomeprazole; Bactrim DS; Fresubin; Methotrexate; Prednisone TAB



Possible Neoral side effects in 57 year old female

Reported by a health professional (non-physician/pharmacist) from Switzerland on 2012-07-20

Patient: 57 year old female

Reactions: Metabolic Acidosis, Diarrhoea, Dehydration, Sedation, Graft Versus Host Disease in Intestine, Disturbance in Attention, Encephalopathy, Immunosuppressant Drug Level Increased, Thrombotic Microangiopathy, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Neoral

Other drugs received by patient: Cymbalta; Navoban; Cellcept; Budenofalk; Carvedilol; Levothyroxine Sodium; Valtrex; Lorapemid; Paspertin; Nexium; Lorazepam; Prednisone TAB; Fragmin



Possible Neoral side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-09

Patient: male

Reactions: Confusional State, Myoclonus, Urinary Incontinence, Encephalopathy, Ammonia Increased, Immunosuppressant Drug Level Increased, Postictal State, Convulsion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Nexium
    Administration route: Oral
    Start date: 2012-05-01
    End date: 2012-05-24

Valacyclovir Hydrochloride
    Start date: 2012-05-03
    End date: 2012-05-24

Neoral
    Administration route: Oral
    Start date: 2012-05-05
    End date: 2012-05-15

Other drugs received by patient: Aldactone; Kardegic; Lasix; Atacand; Keppra; Simvastatin; Glimepiride; Zyloric ^fresenius^; Esidrix



Possible Neoral side effects in 45 year old female

Reported by a physician from Japan on 2012-07-03

Patient: 45 year old female, weighing 50.0 kg (110.0 pounds)

Reactions: C-Reactive Protein Increased, Henoch-Schonlein Purpura, Incorrect Dose Administered, Immunosuppressant Drug Level Increased, White Blood Cell Count Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neoral
    Dosage: 200 mg, unk
    Administration route: Oral
    Start date: 2012-03-27
    End date: 2012-03-29

Neoral
    Dosage: 400 mg, unk
    Administration route: Oral
    Indication: Pustular Psoriasis
    End date: 2012-03-26



Possible Neoral side effects in female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-05-29

Patient: female

Reactions: Multi-Organ Failure, Fungal Infection, Oliguria, Acute Respiratory Distress Syndrome, Immunosuppressant Drug Level Increased, Glucose Tolerance Impaired, Vocal Cord Paralysis, Blood Pressure Decreased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Neoral
    Dosage: 70 mg, unk
    Administration route: Oral
    Indication: Myasthenia Gravis
    Start date: 2008-03-05

Prednisolone
    Dosage: 17.5 mg, unk
    Administration route: Oral
    Indication: Myasthenia Gravis
    Start date: 2007-09-06

Other drugs received by patient: Diltiazem HCL; Isosorbide Dinitrate; Lipitor; Pazufloxacin; Lansoprazole; Sigmart; Elaspol; Lasix; Methylprednisolone



Possible Neoral side effects in female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-05-28

Patient: female

Reactions: Multi-Organ Failure, Fungal Infection, Oliguria, Acute Respiratory Distress Syndrome, Immunosuppressant Drug Level Increased, Glucose Tolerance Impaired, Vocal Cord Paralysis, Blood Pressure Decreased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Neoral
    Dosage: 70 mg, unk
    Administration route: Oral
    Indication: Myasthenia Gravis
    Start date: 2008-03-05

Prednisolone
    Dosage: 17.5 mg, unk
    Administration route: Oral
    Indication: Myasthenia Gravis
    Start date: 2007-09-06

Other drugs received by patient: Diltiazem HCL; Lansoprazole; Isosorbide Dinitrate; Elaspol; Lasix; Sigmart; Lipitor; Pazufloxacin; Methylprednisolone



Possible Neoral side effects in male

Reported by a physician from France on 2012-05-03

Patient: male, weighing 97.0 kg (213.4 pounds)

Reactions: Hydronephrosis, Urethral Stenosis, Pneumonia Aspiration, Disease Progression, Renal Failure, Overdose, Immunosuppressant Drug Level Increased, Acute Prerenal Failure

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neoral
    Dosage: 200 mg, unk
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2011-07-05
    End date: 2011-07-21

Neoral
    Dosage: 450 mg, unk
    Administration route: Oral
    Start date: 2011-07-22
    End date: 2011-07-22

Neoral
    Dosage: 400 mg, unk
    Administration route: Oral
    Start date: 2011-07-23

Other drugs received by patient: Lasix; Simulect; Mycophenolate Mofetil (Cellcept); Prednisolone; Aspirin; Atenolol; Prednisolone; Esomeprazole; Solu-Medrol; Eprex; Valganciclovir; Lasix; Atorvastatin; Alfuzosin HCL



Possible Neoral side effects in female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-30

Patient: female

Reactions: Multi-Organ Failure, Fungal Infection, Oliguria, Acute Respiratory Distress Syndrome, Immunosuppressant Drug Level Increased, Vocal Cord Paralysis, Glucose Tolerance Impaired, Blood Pressure Decreased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Neoral
    Dosage: 70 mg, unk
    Administration route: Oral
    Indication: Myasthenia Gravis
    Start date: 2008-03-05

Prednisolone
    Dosage: 17.5 mg, unk
    Administration route: Oral
    Indication: Myasthenia Gravis
    Start date: 2007-09-06

Other drugs received by patient: Lipitor; Diltiazem HCL; Isosorbide Dinitrate; Lansoprazole; Pazufloxacin; Lasix; Methylprednisolone; Sigmart; Elaspol



Possible Neoral side effects in 45 year old female

Reported by a physician from Japan on 2012-04-30

Patient: 45 year old female, weighing 50.0 kg (110.0 pounds)

Reactions: C-Reactive Protein Increased, Henoch-Schonlein Purpura, Incorrect Dose Administered, Immunosuppressant Drug Level Increased, White Blood Cell Count Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neoral
    Dosage: 400 mg, unk
    Administration route: Oral
    Indication: Pustular Psoriasis
    Start date: 2012-03-21
    End date: 2012-03-26

Neoral
    Dosage: 200 mg, unk
    Administration route: Oral
    Start date: 2012-03-27
    End date: 2012-03-29



Possible Neoral side effects in female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-30

Patient: female

Reactions: Blood Albumin Decreased, Multi-Organ Failure, Gamma-Glutamyltransferase Increased, Acute Respiratory Distress Syndrome, Immunosuppressant Drug Level Increased, Blood Sodium Decreased, White Blood Cell Count Decreased, Alanine Aminotransferase Increased, Vocal Cord Paralysis, Glucose Tolerance Impaired, Haemoglobin Decreased, Fungal Infection, Oliguria, Aspartate Aminotransferase Increased, Platelet Count Decreased, Blood Pressure Decreased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Prednisolone
    Dosage: 17.5 mg, unk
    Administration route: Oral
    Indication: Myasthenia Gravis
    Start date: 2007-09-06

Neoral
    Dosage: 70 mg, unk
    Administration route: Oral
    Indication: Myasthenia Gravis
    Start date: 2008-03-05

Other drugs received by patient: Lipitor; Pazufloxacin; Sigmart; Lasix; Methylprednisolone; Diltiazem HCL; Lansoprazole; Isosorbide Dinitrate; Elaspol



Possible Neoral side effects in male

Reported by a physician from France on 2012-04-27

Patient: male, weighing 97.0 kg (213.4 pounds)

Reactions: Pneumonia Aspiration, Overdose, Renal Failure, Hydronephrosis, Immunosuppressant Drug Level Increased, Acute Prerenal Failure, Disease Progression

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neoral
    Dosage: 450 mg, unk
    Administration route: Oral
    Start date: 2011-07-22
    End date: 2011-07-22

Neoral
    Dosage: 400 mg, unk
    Administration route: Oral
    Start date: 2011-07-23

Neoral
    Dosage: 600 mg, unk
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2011-07-05
    End date: 2011-07-21

Other drugs received by patient: Lasix; Valganciclovir; Esomeprazole Magnesium; Lasix; Atorvastatin; Eprex; Mycophenolate Mofetil (Cellcept); Atenolol; Prednisolone; Simulect; Aspirin; Alfuzosin HCL; Solu-Medrol; Prednisolone



Possible Neoral side effects in 45 year old female

Reported by a physician from Japan on 2012-04-21

Patient: 45 year old female, weighing 50.0 kg (110.0 pounds)

Reactions: C-Reactive Protein Increased, Incorrect Dose Administered, Anaphylactoid Reaction, Immunosuppressant Drug Level Increased, White Blood Cell Count Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neoral
    Dosage: 200 mg, unk
    Administration route: Oral
    Start date: 2012-03-27
    End date: 2012-03-29

Neoral
    Dosage: 400 mg, unk
    Administration route: Oral
    Start date: 2012-03-21
    End date: 2012-03-26



Possible Neoral side effects in female

Reported by a consumer/non-health professional from United States on 2012-03-29

Patient: female

Reactions: Blood Urea Increased, Creatinine Renal Clearance Decreased, Glomerular Vascular Disorder, Blood Triglycerides Increased, Blood Thyroid Stimulating Hormone Increased, Hemiparesis, Cerebrovascular Accident, Blood Parathyroid Hormone Increased, Dysarthria, Haematocrit Decreased, Joint Swelling, Oedema Peripheral, Protein Total Increased, Blood Cholesterol Increased, Immunosuppressant Drug Level Increased, Blood Creatinine Increased, Blood Glucose Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neoral
    Dosage: 75 mg, bid
    Administration route: Oral
    Start date: 2011-09-13

Neoral
    Dosage: 25 mg, tid
    Administration route: Oral
    Indication: Complications of Transplanted Kidney
    Start date: 2011-03-14

Other drugs received by patient: Plavix; Ceftin; Benadryl; Beta Blocking Agents; Metoprolol Succinate; Sulfamethoxazole + Trimethoprim; Metoprolol Succinate; Aspirin; Crestor; Multi-Vitamin; Levothyroxine Sodium; Furosemide; Promethazine HCL; Cyclosporine; Thymoglobulin; Prednisone TAB; Myfortic; Amlodipine Besylate



Possible Neoral side effects in 43 year old female

Reported by a health professional (non-physician/pharmacist) from Switzerland on 2012-03-29

Patient: 43 year old female

Reactions: Myositis, Myalgia, Arthralgia, Hyperkalaemia, Muscular Weakness, Immunosuppressant Drug Level Increased, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neoral
    Dosage: 100 mg, unk
    Administration route: Oral

Neoral
    Dosage: 50 mg, unk
    Administration route: Oral

Neoral
    Dosage: 150 mg, unk
    Administration route: Oral
    Indication: Liver Transplant
    Start date: 2011-10-01

Other drugs received by patient: Sodium Polystyrene Sulfonate; Effexor; Remeron; Sebivo; Dextrose; Insulin; Azathioprine Sodium; Nexium; Aspirin



Possible Neoral side effects in 43 year old female

Reported by a health professional (non-physician/pharmacist) from Switzerland on 2012-03-29

Patient: 43 year old female

Reactions: Myalgia, Myositis, Hyperkalaemia, Arthralgia, Muscular Weakness, Immunosuppressant Drug Level Increased, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neoral
    Dosage: 50 mg, unk
    Administration route: Oral

Neoral
    Dosage: 150 mg, unk
    Administration route: Oral
    Indication: Liver Transplant
    Start date: 2011-10-01

Neoral
    Dosage: 100 mg, unk
    Administration route: Oral

Other drugs received by patient: Dextrose; Sodium Polystyrene Sulfonate; Sebivo; Remeron; Effexor; Nexium; Azathioprine Sodium; Insulin; Aspirin



Possible Neoral side effects in male

Reported by a physician from Japan on 2012-03-23

Patient: male

Reactions: Dyspnoea, Hepatic Function Abnormal, Liver Disorder, Renal Impairment, Renal Failure, Cardiac Failure, Respiratory Failure, Heart Rate Increased, Oedema Peripheral, Pleural Effusion, Immunosuppressant Drug Level Increased, Renal Tubular Necrosis, Hypertension, Oxygen Saturation Decreased

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Neoral

Other drugs received by patient: Allegra; Candesartan Cilexetil; Tigason



Possible Neoral side effects in 86 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-03-20

Patient: 86 year old female

Reactions: Fungal Infection, Acute Respiratory Distress Syndrome, Immunosuppressant Drug Level Increased, Vocal Cord Paralysis, Glucose Tolerance Impaired

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Prednisolone
    Dosage: 17.5 mg, unk
    Administration route: Oral
    Start date: 2007-09-06
    End date: 2009-08-05

Neoral
    Dosage: 35 mg, unk
    Administration route: Oral
    Indication: Myasthenia Gravis
    Start date: 2008-04-24
    End date: 2009-08-05

Other drugs received by patient: Methylprednisolone



Possible Neoral side effects in 86 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-03-20

Patient: 86 year old female

Reactions: Fungal Infection, Acute Respiratory Distress Syndrome, Vocal Cord Paralysis, Immunosuppressant Drug Level Increased, Glucose Tolerance Impaired

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Prednisolone
    Dosage: 17.5 mg, unk
    Administration route: Oral
    Start date: 2007-09-06
    End date: 2009-08-05

Neoral
    Dosage: 35 mg, unk
    Administration route: Oral
    Indication: Myasthenia Gravis
    Start date: 2008-04-24
    End date: 2009-08-05

Other drugs received by patient: Methylprednisolone



Possible Neoral side effects in 86 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-03-16

Patient: 86 year old female

Reactions: Fungal Infection, Acute Respiratory Distress Syndrome, Vocal Cord Paralysis, Glucose Tolerance Impaired, Immunosuppressant Drug Level Increased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Prednisolone
    Dosage: 17.5 mg, unk
    Administration route: Oral
    Start date: 2007-09-06
    End date: 2009-08-05

Neoral
    Dosage: 35 mg, unk
    Administration route: Oral
    Indication: Myasthenia Gravis
    Start date: 2008-04-24
    End date: 2009-08-05

Other drugs received by patient: Methylprednisolone



Possible Neoral side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-07

Patient: male

Reactions: Blood Bilirubin Increased, Rhabdomyolysis, Drug Interaction, Hepatitis, Myalgia, Overdose, Cystic Lymphangioma, Oedema Peripheral, Immunosuppressant Drug Level Increased, Thrombocytopenia, Neuromyopathy, Myositis, Vomiting, Nausea, Anaemia, Muscular Weakness, Toxicity To Various Agents, Eating Disorder, Renal Failure, Diabetic Neuropathy, Diarrhoea, Alopecia, Nervous System Disorder, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neoral

Other drugs received by patient possibly interacting with the suspect drug:
Colchicine
    Dosage: 1 df
    Start date: 2011-07-18
    End date: 2011-07-27

Pravastatin Sodium
    Dosage: 40 mg, qd
    Administration route: Oral
    End date: 2011-07-31

Other drugs received by patient: Aspegic 1000; Humalog; Insulatard NPH Human; Alfuzosin HCL; Ketoprofen; Tramadol HCL; Acetaminophen; Acetaminophen; Sodium Chloride; Kayexalate; Bisoprolol Fumarate; Mianserin; Prednisolone; Ferrous Sulfate TAB; Bactrim; Adenuric; Alfuzosin HCL; Mycophenolate Mofetil (Cellcept); Lasix; Omeprazole; Phosphoneuros



Possible Neoral side effects in 63 year old female

Reported by a physician from Japan on 2012-02-27

Patient: 63 year old female

Reactions: Hepatic Failure, Immunosuppressant Drug Level Increased, Accidental Overdose, Disease Progression

Adverse event resulted in: death

Drug(s) suspected as cause:
Neoral
    Dosage: 5 ml, bid
    Administration route: Oral
    Indication: Liver Transplant
    Start date: 2011-11-28
    End date: 2011-11-30

Neoral
    Dosage: 0.5 ml, bid
    Administration route: Oral

Other drugs received by patient: Lasix; Warfarin Sodium; Prednisolone; Amlodipine



Possible Neoral side effects in female

Reported by a individual with unspecified qualification from Japan on 2012-02-22

Patient: female, weighing 30.0 kg (66.0 pounds)

Reactions: Blood Pressure Increased, Blood Alkaline Phosphatase Increased, Vomiting, Posterior Reversible Encephalopathy Syndrome, Drug Interaction, Immunosuppressant Drug Level Increased, Eye Movement Disorder, Altered State of Consciousness, Clonic Convulsion

Drug(s) suspected as cause:
Neoral
    Dosage: 0.2 ml, bid
    Administration route: Oral
    Start date: 2009-12-12

Neoral
    Dosage: 0.3 ml, bid
    Administration route: Oral
    Indication: Nephrotic Syndrome
    Start date: 2009-11-20
    End date: 2009-11-24

Methylprednisolone
    Dosage: 375 mg, per day
    Indication: Nephrotic Syndrome
    Start date: 2009-11-25
    End date: 2009-11-27

Neoral
    Dosage: 0.6 ml, bid
    Administration route: Oral
    Start date: 2009-11-25
    End date: 2009-11-28

Neoral
    Dosage: 100 mg in two divided doses daily
    Administration route: Oral

Other drugs received by patient: Famotidine; Locholest; Solu-Medrol; Lasix



Possible Neoral side effects in female

Reported by a individual with unspecified qualification from Japan on 2012-02-22

Patient: female, weighing 30.0 kg (66.0 pounds)

Reactions: Blood Alkaline Phosphatase Increased, Blood Pressure Increased, Vomiting, Drug Interaction, Clonic Convulsion, Posterior Reversible Encephalopathy Syndrome, Eye Movement Disorder, Immunosuppressant Drug Level Increased, Altered State of Consciousness

Drug(s) suspected as cause:
Neoral
    Dosage: 100 mg in two divided doses daily
    Administration route: Oral

Neoral
    Dosage: 0.3 ml, bid
    Administration route: Oral
    Indication: Nephrotic Syndrome
    Start date: 2009-11-20
    End date: 2009-11-24

Neoral
    Dosage: 0.6 ml, bid
    Administration route: Oral
    Start date: 2009-11-25
    End date: 2009-11-28

Neoral
    Dosage: 0.2 ml, bid
    Administration route: Oral
    Start date: 2009-12-12

Methylprednisolone
    Dosage: 375 mg, per day
    Indication: Nephrotic Syndrome
    Start date: 2009-11-25
    End date: 2009-11-27

Other drugs received by patient: Locholest; Solu-Medrol; Lasix; Famotidine



Possible Neoral side effects in 11 year old male

Reported by a pharmacist from Japan on 2012-02-21

Patient: 11 year old male

Reactions: Dehydration, Gastroenteritis, Immunosuppressant Drug Level Increased, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neoral
    Dosage: 150 mg, daily
    Administration route: Oral
    Indication: Autoimmune Hepatitis
    End date: 2011-11-01

Neoral
    Dosage: 100 mg, daily
    Administration route: Oral

Neoral
    Dosage: 75 mg, daily
    Administration route: Oral

Neoral
    Dosage: 125 mg, daily (50mg in the morning, 75mg in the evening)
    Administration route: Oral
    Start date: 2011-11-01

Neoral
    Dosage: 100 mg, daily
    Administration route: Oral



Possible Neoral side effects in male

Reported by a physician from Japan on 2012-02-15

Patient: male

Reactions: Neurotoxicity, Renal Impairment, Hepatic Function Abnormal, Toxic Encephalopathy, Toxicity To Various Agents, Immunosuppressant Drug Level Increased, Altered State of Consciousness, Convulsion

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Neoral
    Dosage: 300 mg, daily
    Administration route: Oral
    Indication: Psoriasis
    Start date: 2011-02-16

Neoral
    Dosage: 150 mg/daily
    Administration route: Oral
    Start date: 2011-03-28
    End date: 2011-03-29



Possible Neoral side effects in

Reported by a physician from Japan on 2012-02-09

Patient:

Reactions: Immunosuppressant Drug Level Increased, Accidental Overdose

Adverse event resulted in: death

Drug(s) suspected as cause:
Neoral
    Dosage: 5 cc twice daily
    Administration route: Oral
    Indication: Liver Transplant

Neoral
    Dosage: 0.5 cc twice daily
    Administration route: Oral



Possible Neoral side effects in female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-01-06

Patient: female, weighing 30.0 kg (66.0 pounds)

Reactions: Blood Alkaline Phosphatase Increased, Blood Pressure Increased, Vomiting, Drug Interaction, Clonic Convulsion, Posterior Reversible Encephalopathy Syndrome, Eye Movement Disorder, Immunosuppressant Drug Level Increased, Altered State of Consciousness

Drug(s) suspected as cause:
Neoral
    Dosage: 0.2 ml, bid
    Administration route: Oral
    Start date: 2009-12-12

Neoral
    Dosage: 0.6 ml, bid
    Administration route: Oral
    Start date: 2009-11-25
    End date: 2009-11-28

Methylprednisolone
    Dosage: 375 mg, per day

Neoral
    Dosage: 100 mg in two divided doses daily
    Administration route: Oral

Neoral
    Dosage: 0.3 ml, bid
    Administration route: Oral
    Indication: Nephrotic Syndrome
    Start date: 2009-11-20
    End date: 2009-11-24

Other drugs received by patient: Locholest; Lasix; Famotidine; Solu-Medrol



Possible Neoral side effects in female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-01-05

Patient: female, weighing 30.0 kg (66.0 pounds)

Reactions: Blood Pressure Increased, Blood Alkaline Phosphatase Increased, Vomiting, Drug Interaction, Clonic Convulsion, Posterior Reversible Encephalopathy Syndrome, Immunosuppressant Drug Level Increased, Eye Movement Disorder, Altered State of Consciousness

Drug(s) suspected as cause:
Neoral
    Dosage: 0.6 ml, bid
    Administration route: Oral
    Start date: 2009-11-25
    End date: 2009-11-28

Methylprednisolone
    Dosage: 375 mg, per day

Neoral
    Dosage: 0.2 ml, bid
    Administration route: Oral
    Start date: 2009-12-12

Neoral
    Dosage: 100 mg in two divided doses daily
    Administration route: Oral

Neoral
    Dosage: 0.3 ml, bid
    Administration route: Oral
    Indication: Nephrotic Syndrome
    Start date: 2009-11-20
    End date: 2009-11-24

Other drugs received by patient: Lasix; Locholest; Solu-Medrol; Famotidine



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017